{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:27:27Z","timestamp":1760369247522},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T00:00:00Z","timestamp":1430265600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10822-015-9845-4","type":"journal-article","created":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T08:41:37Z","timestamp":1430210497000},"page":"511-523","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["An integrated suite of modeling tools that empower scientists in structure- and property-based drug design"],"prefix":"10.1007","volume":"29","author":[{"given":"Jianwen A.","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Aliagas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff M.","family":"Blaney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin K.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael F. T.","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man-Ling","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel F.","family":"Ortwine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vickie","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnny","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Gobbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,29]]},"reference":[{"key":"9845_CR1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1021\/ci2003297","volume":"52","author":"M-L Lee","year":"2012","unstructured":"Lee M-L, Aliagas I, Dotson J et al (2012) DEGAS: sharing and tracking target compound ideas with external collaborators. J Chem Inf Model 52:278\u2013284. doi: 10.1021\/ci2003297","journal-title":"J Chem Inf Model"},{"key":"9845_CR2","unstructured":"Benchware 3D Explorer Version 2.3 Tripos, Saint Louis. http:\/\/www.certara.com\/products\/molmod\/bw3de . Accessed 16 Nov 2013"},{"key":"9845_CR3","unstructured":"Molecular operating environment (MOE) Version 2012.10 Chemical Computing Group Inc., Quebec. www.chemcomp.com . Accessed 16 Nov 2013"},{"key":"9845_CR4","unstructured":"The PyMOL Molecular Graphics System Version 1.5 Schrodinger LLC, New York. www.pymol.org . Accessed 16 Nov 2013"},{"key":"9845_CR5","unstructured":"FastROCS Version 1.1 OpenEye Scientific Software, Sante Fe. www.eyesopen.com\/fastrocs . Accessed 16 Nov 2013"},{"key":"9845_CR6","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1021\/jm900818s","volume":"53","author":"A Nicholls","year":"2010","unstructured":"Nicholls A, McGaughey GB, Sheridan RP et al (2010) Molecular shape and medicinal chemistry: a perspective. J Med Chem 53:3862\u20133886. doi: 10.1021\/jm900818s","journal-title":"J Med Chem"},{"key":"9845_CR7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejmech.2013.03.070","volume":"67","author":"J Liang","year":"2013","unstructured":"Liang J, Tsui V, Van Abbema A et al (2013) Lead identification of novel and selective TYK2 inhibitors. Eur J Med Chem 67:175\u2013187. doi: 10.1016\/j.ejmech.2013.03.070","journal-title":"Eur J Med Chem"},{"key":"9845_CR8","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1021\/jm400266t","volume":"56","author":"J Liang","year":"2013","unstructured":"Liang J, Van Abbema A, Balazs M et al (2013) Lead optimization of a 4-aminopyridine benzamide scaffold to identify potent, selective, and orally bioavailable TYK2 inhibitors. J Med Chem 56:4521\u20134536. doi: 10.1021\/jm400266t","journal-title":"J Med Chem"},{"key":"9845_CR9","unstructured":"Pipeline Pilot Version 7.0 Accelrys, San Diego. www.accelrys.com\/products\/pipeline-pilot . Accessed 16 Nov 2013"},{"key":"9845_CR10","unstructured":"Glide Version 6.0 Schrodinger LLC, New York. www.schrodinger.com\/productpage\/14\/5\/ . Accessed 16 Nov 2013"},{"key":"9845_CR11","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739\u20131749. doi: 10.1021\/jm0306430","journal-title":"J Med Chem"},{"key":"9845_CR12","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/jm050362n","volume":"49","author":"GL Warren","year":"2006","unstructured":"Warren GL, Andrews CW, Capelli A-M et al (2006) A critical assessment of docking programs and scoring functions. J Med Chem 49:5912\u20135931. doi: 10.1021\/jm050362n","journal-title":"J Med Chem"},{"key":"9845_CR13","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.drudis.2012.06.011","volume":"17","author":"GL Warren","year":"2012","unstructured":"Warren GL, Do TD, Kelley BP et al (2012) Essential considerations for using protein\u2013ligand structures in drug discovery. Drug Discov Today 17:1270\u20131281. doi: 10.1016\/j.drudis.2012.06.011","journal-title":"Drug Discov Today"},{"key":"9845_CR14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10822-011-9538-6","volume":"26","author":"J Liebeschuetz","year":"2012","unstructured":"Liebeschuetz J, Hennemann J, Olsson T, Groom CR (2012) The good, the bad and the twisted: a survey of ligand geometry in protein crystal structures. J Comput Aided Mol Des 26:169\u2013183. doi: 10.1007\/s10822-011-9538-6","journal-title":"J Comput Aided Mol Des"},{"key":"9845_CR15","unstructured":"MoKa Molecular Discovery, Perugia. www.moldiscovery.com\/soft_moka.php . Accessed 16 Nov 2013"},{"key":"9845_CR16","unstructured":"GRID molecular discovery, Perugia. www.moldiscovery.com\/soft_moka.php . Accessed 3 Jan 2015"},{"key":"9845_CR17","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","volume":"116","author":"PTC Wan","year":"2004","unstructured":"Wan PTC, Garnett MJ, Roe SM et al (2004) Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116:855\u2013867","journal-title":"Cell"},{"key":"9845_CR18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmb.2011.07.020","volume":"412","author":"EV Schneider","year":"2011","unstructured":"Schneider EV, B\u00f6ttcher J, Blaesse M et al (2011) The structure of CDK8\/CycC implicates specificity in the CDK\/cyclin family and reveals interaction with a deep pocket binder. J Mol Biol 412:251\u2013266. doi: 10.1016\/j.jmb.2011.07.020","journal-title":"J Mol Biol"},{"key":"9845_CR19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature07179","volume":"455","author":"R Firestein","year":"2008","unstructured":"Firestein R, Bass AJ, Kim SY et al (2008) CDK8 is a colorectal cancer oncogene that regulates |[bgr]|-catenin activity. Nature 455:547\u2013551. doi: 10.1038\/nature07179","journal-title":"Nature"},{"key":"9845_CR20","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1158\/0008-5472.CAN-09-1704","volume":"69","author":"R Firestein","year":"2009","unstructured":"Firestein R, Hahn WC (2009) Revving the throttle on an oncogene: cDK8 takes the driver seat. Cancer Res 69:7899\u20137901. doi: 10.1158\/0008-5472.CAN-09-1704","journal-title":"Cancer Res"},{"key":"9845_CR21","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","volume":"29","author":"MI Davis","year":"2011","unstructured":"Davis MI, Hunt JP, Herrgard S et al (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol 29:1046\u20131051. doi: 10.1038\/nbt.1990","journal-title":"Nat Biotechnol"},{"key":"9845_CR22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nchembio799","volume":"2","author":"Y Liu","year":"2006","unstructured":"Liu Y, Gray NS (2006) Rational design of inhibitors that bind to inactive kinase conformations. Nat Chem Biol 2:358\u2013364. doi: 10.1038\/nchembio799","journal-title":"Nat Chem Biol"},{"key":"9845_CR23","unstructured":"ROCS Version 3.1.2 OpenEye Scientific Software, Sante Fe. www.eyesopen.com\/rocs . Accessed 16 Nov 2013"},{"key":"9845_CR24","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1021\/ci700052x","volume":"47","author":"GB McGaughey","year":"2007","unstructured":"McGaughey GB, Sheridan RP, Bayly CI et al (2007) Comparison of topological, shape, and docking methods in virtual screening. J Chem Inf Model 47:1504\u20131519. doi: 10.1021\/ci700052x","journal-title":"J Chem Inf Model"},{"key":"9845_CR25","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.drudis.2010.05.016","volume":"15","author":"AP Hill","year":"2010","unstructured":"Hill AP, Young RJ (2010) Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity. Drug Discov Today 15:648\u2013655. doi: 10.1016\/j.drudis.2010.05.016","journal-title":"Drug Discov Today"},{"key":"9845_CR26","first-page":"355","volume":"11","author":"MM Hann","year":"2012","unstructured":"Hann MM, Keser\u0171 GM (2012) Finding the sweet spot: the role of nature and nurture in medicinal chemistry. Nat Publ Group 11:355\u2013365. doi: 10.1038\/nrd3701","journal-title":"Nat Publ Group"},{"key":"9845_CR27","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1021\/mp3006193","volume":"10","author":"DF Ortwine","year":"2013","unstructured":"Ortwine DF, Aliagas I (2013) Physicochemical and DMPK in silico models: facilitating their use by medicinal chemists. Mol Pharm 10:1153\u20131161. doi: 10.1021\/mp3006193","journal-title":"Mol Pharm"},{"key":"9845_CR28","doi-asserted-by":"crossref","unstructured":"Aliagas I A (2015, accepted) Probabilistic method to report predictions from a human liver microsome stability QSAR model: a practical tool for drug discovery. J Comput Aided Mol Des 29(4):327\u2013338. doi: 10.1007\/s10822-015-9838-3","DOI":"10.1007\/s10822-015-9838-3"},{"key":"9845_CR29","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/17425250903042318","volume":"5","author":"DA Price","year":"2009","unstructured":"Price DA, Blagg J, Jones L et al (2009) Physicochemical drug properties associated with in vivotoxicological outcomes: a review. Expert Opin Drug Metab Toxicol 5:921\u2013931. doi: 10.1517\/17425250903042318","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"9845_CR30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","volume":"1","author":"TT Wager","year":"2010","unstructured":"Wager TT, Hou X, Verhoest PR, Villalobos A (2010) Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties. ACS Chem Neurosci 1:435\u2013449. doi: 10.1021\/cn100008c","journal-title":"ACS Chem Neurosci"},{"key":"9845_CR31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"C Lipinski","year":"1997","unstructured":"Lipinski C, Lombardo F, Dominy B, Feeney P (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3\u201325","journal-title":"Adv Drug Deliv Rev"},{"key":"9845_CR32","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1124\/dmd.111.040840","volume":"39","author":"L Liu","year":"2011","unstructured":"Liu L, Halladay JS, Shin Y et al (2011) Significant species difference in amide hydrolysis of GDC-0834, a novel potent and selective Bruton\u2019s tyrosine kinase inhibitor. Drug Metab Dispos 39:1840\u20131849. doi: 10.1124\/dmd.111.040840","journal-title":"Drug Metab Dispos"},{"key":"9845_CR33","doi-asserted-by":"crossref","first-page":"8007","DOI":"10.1021\/jm300867c","volume":"55","author":"TP Heffron","year":"2012","unstructured":"Heffron TP, Salphati L, Alicke B et al (2012) The Design and identification of brain penetrant inhibitors of phosphoinositide 3-kinase \u03b1. J Med Chem 55:8007\u20138020. doi: 10.1021\/jm300867c","journal-title":"J Med Chem"},{"key":"9845_CR34","doi-asserted-by":"crossref","first-page":"9416","DOI":"10.1021\/jm301020q","volume":"55","author":"AA Estrada","year":"2012","unstructured":"Estrada AA, Liu X, Baker-Glenn C et al (2012) Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors. J Med Chem 55:9416\u20139433. doi: 10.1021\/jm301020q","journal-title":"J Med Chem"},{"key":"9845_CR35","unstructured":"Gobbi A, Lee M-L Aestel Open source software San Francisco. http:\/\/sourceforge.net\/projects\/aestel\/ . Accessed 16 Nov 2013"},{"key":"9845_CR36","unstructured":"OEChem Toolkit OpenEye Scientific Software, Sante Fe. www.eyesopen.com\/oechem-tk . Accessed 16 Nov 2013"},{"key":"9845_CR37","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/ci100031x","volume":"50","author":"PCD Hawkins","year":"2010","unstructured":"Hawkins PCD, Skillman AG, Warren GL et al (2010) Conformer generation with OMEGA: algorithm and validation using high quality structures from the protein databank and Cambridge structural database. J Chem Inf Model 50:572\u2013584. doi: 10.1021\/ci100031x","journal-title":"J Chem Inf Model"},{"key":"9845_CR38","unstructured":"Grapheme Toolkit OpenEye Scientific Software, Sante Fe. www.eyesopen.com\/grapheme-tk . Accessed 16 Nov 2013"},{"key":"9845_CR39","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1021\/ci700189s","volume":"47","author":"M-H Hao","year":"2007","unstructured":"Hao M-H, Haq O, Muegge I (2007) Torsion angle preference and energetics of small-molecule ligands bound to proteins. J Chem Inf Model 47:2242\u20132252. doi: 10.1021\/ci700189s","journal-title":"J Chem Inf Model"},{"key":"9845_CR40","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","volume":"17","author":"TA Halgren","year":"1998","unstructured":"Halgren TA (1998) Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comput Chem 17:490\u2013519. doi: 10.1002\/(SICI)1096-987X(199604)17:5\/6<490:AID-JCC1>3.0.CO;2-P","journal-title":"J Comput Chem"},{"key":"9845_CR41","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1021\/jm100112j","volume":"53","author":"C Bissantz","year":"2010","unstructured":"Bissantz C, Kuhn B, Stahl M (2010) A medicinal chemist\u2019s guide to molecular interactions. J Med Chem 53:5061\u20135084. doi: 10.1021\/jm100112j","journal-title":"J Med Chem"},{"key":"9845_CR42","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","volume":"267","author":"G Jones","year":"1997","unstructured":"Jones G, Willett P, Glen RC et al (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267:727\u2013748. doi: 10.1006\/jmbi.1996.0897","journal-title":"J Mol Biol"},{"key":"9845_CR43","unstructured":"Vortex Dotmatics, Bishops Stortford. www.dotmatics.com\/products\/vortex Accessed 16 Nov 2013"},{"key":"9845_CR44","unstructured":"Spotfire TIBCO Software, Boston. www.spotfire.tibco.com . Accessed 16 Nov 2013"},{"key":"9845_CR45","unstructured":"CMR Biobyte Corp, Claremont. www.biobyte.com . Accessed 16 Nov 2013"},{"key":"9845_CR46","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","volume":"43","author":"P Ertl","year":"2000","unstructured":"Ertl P, Rohde B, Selzer P (2000) Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 43:3714\u20133717. doi: 10.1021\/jm000942e","journal-title":"J Med Chem"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-015-9845-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-015-9845-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-015-9845-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T01:23:07Z","timestamp":1559265787000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-015-9845-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,29]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["9845"],"URL":"https:\/\/doi.org\/10.1007\/s10822-015-9845-4","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,29]]}}}